publication date: Sep. 3, 2010Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal. Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering. FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove. Committee To Set Research Agenda On Breast Cancer. Justice Department Appeals Injunction On Stem Cell Research. Download PDF
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.